Sequence diversity and functional characterization of the 5′-regulatory region of human CYP2C19

被引:9
作者
Arefayene, M
Skaar, TC
Zhao, XJ
Rae, JM
Tanus-Santos, JE
Brinkmann, U
Brehm, I
Salat, U
Nguyen, A
Desta, Z
Flockhart, DA
机构
[1] Indiana Univ, Sch Med, Dept Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA
[2] Epidauros Biotechnol AG, Bernried, Germany
[3] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
来源
PHARMACOGENETICS | 2003年 / 13卷 / 04期
关键词
CYP2C19; promoter; sequence; polymorphism; transcription factor; omeprazole; rifampin;
D O I
10.1097/00008571-200304000-00004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cytochrome P4502C19 (CYP2C19) plays an important role in drug biotransformation and has been shown to be genetically polymorphic. While polymorphisms in the coding region that have large effects on activity are well described, until recently, a lack of knowledge of the promoter sequence has hindered efforts to study it. Genetic variants in the promoter region have not been described and factors that influence its gene expression via promotor regulation remain largely undefined. We have cloned and sequenced 1.8 kb of the human CYP2C19 promoter. This promoter contains a number of putative transcription factor sites, including HepG2-specific factor 1, glucocorticoid response element, estrogen receptor element, constitutive androstane receptor and peroxisome proliferator-activated receptor. Sequencing of DNA obtained from 67 individuals identified eight single nucleotide polymorphisms within this region. No sequence of a known human pregnane X receptor response element was found in this section of the CYP2C19 promoter, despite the known effect of rifampin on the expression of this gene. A plasmid containing the 1.8-kb CYP2C19 promoter coupled to a luciferase reporter gene has been constructed and demonstrated to be functional and sensitive to induction by omeprazole in HuH7 cells. Nested deletions of CYP2C19 promoter were generated and the ability of serial promoter deletion constructs to activate luciferase expression in the HepG2 cell line was analysed. These data make possible future studies to elucidate the molecular mechanisms by which CYP2C19 can be induced in clinical settings and the consequences of genetic variability in its promoter.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 22 条
[1]   EFFECT OF OMEPRAZOLE TREATMENT ON DIAZEPAM PLASMA-LEVELS IN SLOW VERSUS NORMAL RAPID METABOLIZERS OF OMEPRAZOLE [J].
ANDERSSON, T ;
CEDERBERG, C ;
EDVARDSSON, G ;
HEGGELUND, A ;
LUNDBORG, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :79-85
[2]   Pharmacokinetics and effect an caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole [J].
Andersson, T ;
Holmberg, J ;
Röhss, K ;
Walan, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (04) :369-375
[3]   GENE STRUCTURE AND UPSTREAM REGULATORY REGIONS OF HUMAN CYP2C9 AND CYP2C18 [J].
DEMORAIS, SMF ;
SCHWEIKL, H ;
BLAISDELL, J ;
GOLDSTEIN, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (01) :194-201
[4]   Clinical significance of the cytochrome P4502C19 genetic polymorphism [J].
Desta, Z ;
Zhao, XJ ;
Shin, JG ;
Flockhart, DA .
CLINICAL PHARMACOKINETICS, 2002, 41 (12) :913-958
[5]   The induction effect of rifampicin on activity of mephenytoin 4′-hydroxylase related to M1 mutation of CYP2C19 and gene dose [J].
Feng, HJ ;
Huang, SL ;
Wang, W ;
Zhou, HH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (01) :27-29
[6]   Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans [J].
Fuhr, U .
CLINICAL PHARMACOKINETICS, 2000, 38 (06) :493-504
[7]   Transcriptional regulation of CYP2C9 gene -: Role of glucocorticoid receptor and constitutive androstane receptor [J].
Gerbal-Chaloin, S ;
Daujat, M ;
Pascussi, JM ;
Pichard-Garcia, L ;
Vilarem, MJ ;
Maurel, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :209-217
[8]  
Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242
[9]   Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].
Goldstein, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355
[10]   GENE STRUCTURE OF CYP3A4, AN ADULT-SPECIFIC FORM OF CYTOCHROME-P450 IN HUMAN LIVERS, AND ITS TRANSCRIPTIONAL CONTROL [J].
HASHIMOTO, H ;
TOIDE, K ;
KITAMURA, R ;
FUJITA, M ;
TAGAWA, S ;
ITOH, S ;
KAMATAKI, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02) :585-595